Polyrizon Stock Surges on Allergy Blocker Human Study

By EC Assets · Published 15 June 2026

Polyrizon Ltd shares gained after the company initiated a human study for its allergy blocker. The stock rose on Monday following the announcement. Polyrizon Ltd shares rose 9.2% on Monday. This increase occurred after the company initiated a nasal residence time study for its allergy blocker. The company's stock experienced an 11% decline over the past week. Despite this decline, shares have surged 122% over a longer period. Polyrizon Ltd trades on the NASDAQ under the ticker PLRZ. This article is intended for informational purposes only. It does not constitute investment advice.